Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Is Angiographic Vasospasm an Epiphenomenon?
Author(s) -
Mervyn D.I. Vergouwen,
Marinus Vermeulen,
Yvo B.W.E.M. Roos
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.537985
Subject(s) - medicine , subarachnoid hemorrhage , epiphenomenon , vasospasm , ischemia , cardiology , cerebral vasospasm , anesthesia , philosophy , epistemology
To the Editor:We would like to congratulate the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) investigators with the completion of this large phase IIb study, investigating the effect of the endothelin receptor A antagonist clazosentan in patients with aneurysmal hemorrhage.1 We have a few comments.First, the CONSCIOUS-1 study has angiographic vasospasm as a primary end point. Although we understand this from a pathophysiological point of view, namely that angiographic vasospasm is caused by endothelin release and might be counteracted by an endothelin …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom